Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum CalciMedica Inc CALC

CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora... see more

NDAQ:CALC - Post Discussion

CalciMedica Inc > PDF Graycliff $GRAY Corporate Presentation
View:
Post by alphaflight on Apr 21, 2021 10:56pm

PDF Graycliff $GRAY Corporate Presentation

 
Untitled | by AlphaPortfolios

Shakespeare Project
 

The Shakespeare project is located in the area of the historic Shakespeare mine, ~80 km west of Sudbury, Ontario. The Shakespeare mine operated from 1903 to 1907 and produced 2,959 oz of gold, when gold was US$19 per oz.
 
SEE THE COMPLETE CORPORATE PRESENTATION AS A PRINTABLE PDF, HERE: https://bit.ly/3at77vU
 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities